Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · IEX Real-Time Price · USD
7.36
+0.04 (0.55%)
At close: Apr 12, 2024, 12:00 AM
7.32
-0.04 (-0.54%)
After-hours: Apr 15, 2024, 4:20 PM EDT
Tango Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Tango Therapeutics stock have an average target of 17.25, with a low estimate of 16 and a high estimate of 18. The average target predicts an increase of 134.38% from the current stock price of 7.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TNGX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $17 | Strong Buy | Maintains | $16 → $17 | +130.98% | Mar 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $18 | Buy | Initiates | $18 | +144.57% | Feb 12, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +117.39% | Dec 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $16 | Strong Buy | Maintains | $11 → $16 | +117.39% | Aug 11, 2023 |
Financial Forecast
Revenue This Year
28.61M
from 36.53M
Decreased by -21.67%
Revenue Next Year
30.09M
from 28.61M
Increased by 5.16%
EPS This Year
-1.31
from -1.08
EPS Next Year
-1.42
from -1.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 44.3M | 60.6M | 69.1M | 252.8M | 611.1M |
| Avg | 28.6M | 30.1M | 30.8M | 245.6M | 593.7M |
| Low | n/a | n/a | n/a | 236.0M | 570.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 21.3% | 111.8% | 129.6% | 720.0% | 148.8% |
| Avg | -21.7% | 5.2% | 2.5% | 696.6% | 141.7% |
| Low | - | - | - | 665.3% | 132.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.24 | -1.24 | -1.42 | -0.07 | 2.10 |
| Avg | -1.31 | -1.42 | -1.52 | -0.07 | 2.04 |
| Low | -1.41 | -1.59 | -1.81 | -0.07 | 1.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.